Total Funding
50
37
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
167985
EmeraMed Limited is a biotechnology firm developing the metal chelator and antioxidant Irminix.
Ragnar Klingberg: Executive VP
Boyd Haley: Chief Scientist and CEOPast Role: University of Kentucky, Scientist at the Markey Cancer Center
About the Company
EmeraMed Limited is a privately held limited liability company (corporation) organized and headquartered in the Republic of Ireland. The Company currently operates in Ireland, Sweden, and the United States. The Company’s ownership group is primarily composed of physicians, dentists, and patients with personal experience of the product from when it
was previously sold as a dietary supplement. If you are interested in learning more about the Company, please use our Contact page to request additional information.
